Posted on 10/26/16
Alzheon Publishes New Analyses from Phase 3 Studies Showing Clinical Benefit of Tramiprosate in Alzheimer’s Patients
Results published today in The Journal of the Prevention of Alzheimer’s Disease (JPAD) describe analyses of Phase 3 data for the investigational amyloid-targeted drug, tramiprosate, in . . .
Posted on 10/26/16
Selecta Biosciences Initiates Phase 2 Clinical Trial of SEL-212
WATERTOWN, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company developing a novel class of targeted antigen-specific immune therapies, today . . .
Posted on 10/26/16
4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall
SOME GREAT DRUG STOCKS COULD BE HIDING IN PLAIN VIEW. IMAGE SOURCE: GETTY IMAGES.U.S. stocks have been taken for a wild ride in 2016, but at . . .
Posted on 10/26/16
Better Buy: Celldex Therapeutics, Inc. vs. bluebird bio, Inc.
IMAGE SOURCE: GETTY IMAGES.Pipeline vs. pipeline.That's the match-up investors must consider when deciding which clinical-stage biotech stock to buy. Two such biotech stocks attracting plenty of . . .
Posted on 10/26/16
Collegium Proposes Stock Offering
CANTON, Mass., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it has commenced an underwritten public offering of shares of its . . .
Posted on 10/24/16
athenahealth's (ATHN) CEO Jonathan Bush on Q3 2016 Results - Earnings Call Transcript
athenahealth, Inc. (NASDAQ:ATHN)Q3 2016 Earnings Conference CallOctober 21, 2016, 8:00 am ETExecutivesDana Quattrochi - Executive Director, IRJonathan Bush - Chairman & CEOKarl Stubelis - CFOAnalystsMohan Naidu . . .
Posted on 10/24/16
Athenahealth, Inc. Q3 Earnings Soar With Solid Customer Growth
IMAGE SOURCE: GETTY IMAGES.Athenahealth (NASDAQ:ATHN) is accustomed to rapid sales growth. It's expected -- by the company and by investors. In the second quarter, the healthcare . . .
Posted on 10/23/16
Evidation Health and Brigham and Women’s Innovation Hub Join Forces
SAN MATEO, Calif. & BOSTON--(BUSINESS WIRE)--Brigham and Women’s Innovation Hub (iHub) and Evidation Health announce a collaboration to measure the real life impact of digital health . . .
Posted on 10/21/16
ProEx Physical Therapy Celebrates 15th Anniversary
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine is celebrating its 15th anniversary, a decade and a half highlighted by outstanding . . .
Posted on 10/21/16
Is This Berkshire-Like Move The Right Thing For Gilead?
Gilead (NASDAQ:GILD), along with the biotech sector as a whole, has sold off sharply over the last weeks, marking a new 52 week low of just . . .
Posted on 10/21/16
athenahealth Reports Third Quarter Fiscal Year 2016 Results
WATERTOWN, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services and mobile applications for healthcare providers nationwide, today announced . . .
Posted on 10/21/16
Hartford HealthCare Headache Center Awarded First Ever IMPACT Grant from Migraine Research Foundation
Dr. Brian Grosberg, medical director of the Hartford HealthCare Headache Program, was awarded the inaugural Migraine Research Foundation "Impact" Award, a$250,000 grant that will fund leading-edge . . .
Posted on 10/21/16
Emulate Announces Strategic Collaboration with Covance
BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today a strategic collaboration with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) that seeks to integrate Emulate’s Organs-on-Chips technology into preclinical . . .
Posted on 10/21/16
NeuroMetrix Reports Q3 2016 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter and nine month periods ended September 30, 2016.The Company operates . . .
Posted on 10/20/16
3 Reasons Bristol-Myers Is a Buy
IMAGE SOURCE: BRISTOL-MYERS SQUIBB.Fresh off a data release announcement providing full details of Opdivo's failure in its Phase 3 CheckMate-026 study, Bristol-Myers Squibb (NYSE:BMY) shares dipped . . .
Posted on 10/20/16
Repligen to Report Third Quarter 2016 Financial Results
WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report third quarter 2016 financial results on Thursday, November . . .
Posted on 10/20/16
Dominion Announces Renewable Energy Sales Agreements With MIT, Boston Medical Center, Post Office Square Redevelopment Corporation
As part of its long-term plan to bring online at least 500 megawatts of solar electric generating capacity in North Carolina and Virginia, Dominion (NYSE: D) . . .
Posted on 10/20/16
Cerulean Announces Technology Platform Collaboration
WALTHAM, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (NASDAQ:CERU), a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that the Company has entered into a strategic collaboration with Novartis . . .
Posted on 10/20/16
Cambridge BioMarketing Expands to West Coast with Oakland Office Opening
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, the world’s leading orphan and specialty communications agency, announced today the official opening of its West Coast office in Oakland, CA. Led . . .
Posted on 10/19/16
Better Buy: Biogen Inc. vs. Gilead Sciences, Inc.
IMAGE SOURCE: GETTY IMAGES.Two of the biggest biotechs around have also been two of the best long-term investments. If you had bought shares of Biogen (NASDAQ:BIIB) . . .
Posted on 10/19/16
Better Buy: Agenus Inc. vs. Bellicum Pharmaceuticals Inc.
IMAGE SOURCE: GETTY IMAGES.It's been a good year for clinical-stage biotech Agenus Inc. (NASDAQ:AGEN): Its shares are up over 20% in 2016. Meanwhile, shares of peer . . .
Posted on 10/18/16
Southern New Hampshire Health Recognized as a “Family Favorite” Award Recipient by Parenting New Hampshire magazine
NASHUA, N.H.--(BUSINESS WIRE)--Southern New Hampshire Health has been selected by the readers of Parenting New Hampshire as a “Family Favorite” award recipient for the categories of: . . .
Posted on 10/18/16
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
IMAGE SOURCE: GETTY IMAGES.Only 12% of patients with advanced kidney cancer survive five years or more. Exelixis(NASDAQ:EXEL) hopes to increase that number, and based on its . . .
Posted on 10/18/16
Blue Cross Medicare Plans Top Ratings With 5 Stars
Blue Cross Blue Shield of Massachusetts (Blue Cross)Medicare plans are among the top-rated plans in the country, according to the Centers for Medicare & Medicaid Services . . .
Posted on 10/17/16
Hillary Clinton vs. Donald Trump on Medicare
IMAGE SOURCE: GETTY IMAGES.Medicare is an important issue for Americans -- not only does the program provide health coverage for more than 50 million people, but . . .
Boston
